Tempest Therapeutics, Inc.

TPST ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Feb 11, 2026 8-K
SCHEDULE 13D Feb 10, 2026
4 Feb 6, 2026
3 Feb 6, 2026
8-K Feb 6, 2026 8-K
4 Jan 28, 2026
4 Jan 28, 2026
4 Jan 28, 2026
4 Jan 28, 2026
8-K Jan 28, 2026 8-K
SCHEDULE 13G Jan 21, 2026
8-K Jan 9, 2026 8-K
EFFECT Dec 31, 2025
ARS Dec 31, 2025 ARS
DEF 14A Dec 31, 2025 DEF 14A
CORRESP Dec 30, 2025
CORRESP Dec 23, 2025
UPLOAD Dec 12, 2025
S-1 Dec 9, 2025 S-1
PRE 14A Dec 2, 2025 PRE 14A
8-K Nov 26, 2025 8-K
424B5 Nov 25, 2025 424B5
DEFA14A Nov 19, 2025 DEFA14A
8-K Nov 19, 2025 8-K
10-Q Nov 5, 2025 10-Q
← Newer Page 4 of 42 · 1047 filings Older →